The Role of Probiotics and Prebiotics in Human Health

A special issue of Foods (ISSN 2304-8158). This special issue belongs to the section "Food Microbiology".

Deadline for manuscript submissions: closed (31 December 2017) | Viewed by 17532

Special Issue Editor


E-Mail Website
Guest Editor
Cardiff School of Health Sciences, Centre for Nutrition, Dietetics & Food Science, Cardiff Metropolitan University, Llandaff Campus, Western Avenue, Cardiff CF5 2YB, Wales, UK
Interests: probiotics; bioactive compounds in foods; dairy products for their use in food formulations as health promoting nutraceuticals

Special Issue Information

Dear Colleagues,

Interest in improving human health through diet, and its active ingredients, has attracted many researchers, as well as industrialists and legislators, especially in the last few decades. Generally, fermented foods contain many lactic acid bacteria, some of which have been recognised as probiotics, such as those belong to Lactobacillus spp. and Bifidobacterium spp., which could be part of the microbiota in the gut.

Prebiotics, which have been recognised as non-digestible constituents in foods, are preferentially utilised by probiotic bacteria in the lower part of the digestive system. They are part of almost everyday diet of plant origin. The presence of both, probiotics and prebiotics, can result in symbiosis and several health claims have been attributed to the presence of both.

Most of the health claims that have been attributed to probiotics are for their direct or indirect physiological role in human body, which include minimising the risk of heart disease through cholesterol reduction, lowering blood pressure and as anti-thrombotic agents. The other health benefits include anti-carcinogenic, anti-inflammatory, antimicrobial activities, modulating the immune system and many others. Such improvement in human health could minimise the reliance on pharmaceutical drugs and to emphasis more on nutraceuticals. There are still a lot of research that is taking place for the safe delivery of the probiotics through microencapsulation and the mechanism of action for all these health benefits.

Dr. Ara Kanekanian
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Foods is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

20 pages, 281 KiB  
Review
The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome
by Ashton Harper, Malwina M. Naghibi and Davinder Garcha
Foods 2018, 7(2), 13; https://0-doi-org.brum.beds.ac.uk/10.3390/foods7020013 - 26 Jan 2018
Cited by 61 | Viewed by 17064
Abstract
Irritable bowel syndrome is a highly prevalent gastrointestinal disorder that threatens the quality of life of millions and poses a substantial financial burden on healthcare systems around the world. Intense research into the human microbiome has led to fascinating discoveries which directly and [...] Read more.
Irritable bowel syndrome is a highly prevalent gastrointestinal disorder that threatens the quality of life of millions and poses a substantial financial burden on healthcare systems around the world. Intense research into the human microbiome has led to fascinating discoveries which directly and indirectly implicate the diversity and function of this occult organ in irritable bowel syndrome (IBS) pathophysiology. The benefit of manipulating the gastrointestinal microbiota with diet and probiotics to improve symptoms has been demonstrated in a wealth of both animal and human studies. The positive and negative mechanistic roles bacteria play in IBS will be explored and practical probiotic and dietary choices offered. Full article
(This article belongs to the Special Issue The Role of Probiotics and Prebiotics in Human Health)
Back to TopTop